EurekAlert! -- AURORA, Colo. (Jan. 20, 2011)--Cancer scientists have designed the first molecular test to predict which bladder cancer patients may have cancer involvement in their lymph nodes at the time of surgery—which could help doctors determine which patients are good candidates for pre-surgical, or neo-adjuvant, chemotherapy.
